HomePress Releases Press Releases A comprehensive library of Ipsen media releases for investors and members of the press. Explore press releases Filter Topics Corporate Oncology Rare Diseases Neuroscience Period 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 Filter by X recent search Reset Showing: 1 – 05 of 26 Press Releases Show 05 10 20 30 40 50 Sort Descending Ascending 12 March 2026 12 March 2026 Ipsen appoints Michelle C. Werner as EVP, President of North America 23 October 2025 23 October 2025 Ipsen launches educational initiative to support teens and young adults moving from pediatric to adult healthcare 18 November 2024 18 November 2024 Bylvay® (odevixibat) data shows sustained improvement in severe itch and serum bile acid levels in patients with PFIC and ALGS 15 November 2024 15 November 2024 Iqirvo® (elafibranor) data shows efficacy and safety for up to 3 years in patients with PBC with improvements in fatigue and pruritus 10 June 2024 10 June 2024 Ipsen’s Iqirvo® receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primary biliary cholangitis 1234…6